title: Alcohol biomarker screening in medical and surgical settings.
abstract: This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.
authors.affiliation: Center for Drug and Alcohol Programs, Charleston, South Carolina 29425, USA. millerpm@musc.edu
authors.forename: Peter M
authors.initials: PM
authors.lastname: Miller
authors.forename: Claudia
authors.initials: C
authors.lastname: Spies
authors.forename: Tim
authors.initials: T
authors.lastname: Neumann
authors.forename: Martin A
authors.initials: MA
authors.lastname: Javors
authors.forename: A M
authors.initials: AM
authors.lastname: Hoyumpa
authors.forename: John
authors.initials: J
authors.lastname: Roache
authors.forename: Amy
authors.initials: A
authors.lastname: Webb
authors.forename: Maryam
authors.initials: M
authors.lastname: Kashi
authors.forename: Francis E
authors.initials: FE
authors.lastname: Sharkey
authors.forename: Raymond F
authors.initials: RF
authors.lastname: Anton
authors.forename: Brent M
authors.initials: BM
authors.lastname: Egan
authors.forename: Jan
authors.initials: J
authors.lastname: Basile
authors.forename: Shaun
authors.initials: S
authors.lastname: Nguyen
authors.forename: Michael F
authors.initials: MF
authors.lastname: Fleming
authors.forename: Kathryn Sullivan
authors.initials: KS
authors.lastname: Dillie
mesh_terms: D000435:Alcoholic Intoxication / Q000097:blood / Q000175:diagnosis*; D000437:Alcoholism / Q000097:blood / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood*; D003365:Costs and Cost Analysis; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000097:blood / Q000175:diagnosis; D008111:Liver Function Tests / Q000191:economics; D008403:Mass Screening / Q000191:economics; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control*; D011237:Predictive Value of Tests; D011300:Preoperative Care / Q000191:economics; D011320:Primary Health Care / Q000191:economics; D014168:Transferrin / Q000031:analogs & derivatives / Q000378:metabolism; D014947:Wounds and Injuries / Q000097:blood / Q000601:surgery; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D015415:Biomarkers; D014168:Transferrin; C056759:carbohydrate-deficient transferrin; D005723:gamma-Glutamyltransferase